NCT07140796

Brief Summary

This study aims to investigate the effects of gluteus medius-focused blood flow restriction (BFR) training, with or without the addition of radial shockwave therapy, on lower limb alignment in adults with genu varum. The study uses a crossover design and evaluates changes in Q-angle(Quadriceps-angle) and plantar pressure as primary outcomes. All interventions are non-invasive and supervised, and the goal is to identify effective therapeutic strategies to improve biomechanical alignment in individuals with bowed legs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

September 10, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

Same day

First QC Date

August 22, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

Genu varumBlood Flow RestrictionBFR TrainingRadial Shockwave TherapyQ-anglePlantar pressure

Outcome Measures

Primary Outcomes (1)

  • Plantar pressure Distribution

    Plantar pressure will be assessed using the TPScan system while participants walk barefoot over the pressure mat. The system will analyze peak pressure, pressure-time integral, and center of pressure trajectory in both feet. Data will be collected under two conditions (BFR alone vs. BFR + rESWT), and compared to evaluate the effects of the intervention.

    Baseline and 4 Weeks Post-intervention

Secondary Outcomes (1)

  • Quadriceps Angle (Q-angle)

    At Baseline and 4 Weeks After Each Intervention Period

Study Arms (2)

BFR Only

EXPERIMENTAL

Participants in this group will undergo blood flow restriction (BFR) training alone. BFR training will be performed using a thigh cuff at a pressure estimated based on the participant's thigh circumference and blood pressure. Squats will be performed with 15% of body weight and hip internal rotation at 15 degrees, twice per week for 4 weeks.

Behavioral: Blood Flow Restriction TrainingDevice: Radial Extracorporeal Shockwave Therapy

BFR + Shockwave

EXPERIMENTAL

Participants in this group will receive a combination of blood flow restriction (BFR) training and radial extracorporeal shockwave therapy (rESWT). BFR training will be conducted as in the other arm. Additionally, rESWT will be applied to the gluteus medius region before each exercise session, with 2000 pulses per session, twice per week for 4 weeks.

Behavioral: Blood Flow Restriction Training

Interventions

Participants perform squats with 15% of their body weight under blood flow restriction using a thigh cuff. Hip internal rotation is set at 15 degrees. The training is conducted twice a week for 4 weeks. Cuff pressure is estimated using a predictive formula based on thigh circumference and systolic blood pressure.

BFR + ShockwaveBFR Only

Radial extracorporeal shockwave therapy (rESWT) is applied to the gluteus medius region prior to each exercise session. The protocol includes 2000 pulses per session, applied twice per week for 4 weeks, using a radial shockwave device.

BFR Only

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged between 20 and 40 years
  • Diagnosed with genu varum (inter-knee distance ≥ 3 cm in standing position)
  • No pain or surgery history in lower extremities within the last 6 months
  • Able to walk independently without assistance
  • Provide written informed consent

You may not qualify if:

  • Neurological or musculoskeletal disorders affecting gait or posture
  • Current use of medication affecting musculoskeletal or circulatory function
  • Previous surgery on the spine, pelvis, or lower limbs
  • Contraindications to shockwave therapy or BFR training (e.g., thromboembolic - disorders, deep vein thrombosis, cancer, etc.)
  • Participation in other clinical trials within the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gangnam Su Rehabilitation Medicine Manual & Exercise Therapy Center

Seoul, Seoul, 06606, South Korea

Location

MeSH Terms

Conditions

Genu Varum

Interventions

Blood Flow Restriction Therapy

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is open label because both the participants and investigators are aware of the intervention being administered. Due to the physical nature of the interventions (exercise and shockwave therapy), blinding was not feasible.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This study uses a crossover design in which each participant receives two different interventions-gluteus medius-focused blood flow restriction (BFR) training alone and BFR training combined with radial extracorporeal shockwave therapy (rESWT)-in randomized order, with a washout period between the phases.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 22, 2025

First Posted

August 26, 2025

Study Start

September 10, 2025

Primary Completion

September 10, 2025

Study Completion

January 1, 2026

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

"IPD will not be shared because the data are limited to a small sample of clinical patients and involve privacy-sensitive health information."

Locations